Cargando…
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
BACKGROUND: Opioids are the most widely used analgesics for the treatment of clinical pain. They produce their therapeutic effects by binding to μ-opioid receptors (MORs), which are 7 transmembrane domain (7TM) G-protein-coupled receptors (GPCRs), and inhibiting cellular activity. However, the analg...
Autores principales: | Gris, Pavel, Gauthier, Josee, Cheng, Philip, Gibson, Dustin G, Gris, Denis, Laur, Oskar, Pierson, John, Wentworth, Sean, Nackley, Andrea G, Maixner, William, Diatchenko, Luda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894766/ https://www.ncbi.nlm.nih.gov/pubmed/20525224 http://dx.doi.org/10.1186/1744-8069-6-33 |
Ejemplares similares
-
Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia
por: Oladosu, Folabomi A., et al.
Publicado: (2015) -
Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase
por: Tchivileva, Inna E, et al.
Publicado: (2009) -
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
por: Shabalina, Svetlana A., et al.
Publicado: (2009) -
Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation
por: Convertino, Marino, et al.
Publicado: (2015) -
Low Enzymatic Activity Haplotypes of the Human Catechol-O-Methyltransferase Gene: Enrichment for Marker SNPs
por: Nackley, Andrea G., et al.
Publicado: (2009)